prescription glp-1 medications Infographic New Daily GLP-1 Weight Loss

The LEADER trial demonstrated a 13% reduction in MACE with liraglutide in high-risk patients with T2D

Growing Scrutiny Around GLP1 Safety and Long-Term Value From a benefits perspective, understanding concerns about GLP-1 use helps you know what to look for and how it may influence your long-term plan performance

Amyloid PET and plasma p-tau confirm eligibility

At Nuviva we recommend starting with small doses to help your body adjust and learn to tolerate this medication

Studies have shown significant reductions in total body weight and waist circumference in individuals with obesity, positioning it as a highly effective option for long-term weight loss

The short answer is: not necessarily, but it depends on your individual circumstances